title: Coronary artery calcium scanning should be used for primary prevention: pros and cons.
authors.affiliation: Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.
authors.forename: Khurram
authors.initials: K
authors.lastname: Nasir
authors.forename: Leslee J
authors.initials: LJ
authors.lastname: Shaw
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Budoff
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ridker
authors.forename: Jessica M
authors.initials: JM
authors.lastname: Peña
mesh_terms: D058070:Asymptomatic Diseases; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011322:Primary Prevention; D018570:Risk Assessment; D012307:Risk Factors; D061205:Vascular Calcification / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy
chemical_list: D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D002097:C-Reactive Protein